BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1655782)

  • 1. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors.
    Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A
    J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
    Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
    J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.
    Kjeldsen T; Andersen AS; Wiberg FC; Rasmussen JS; Schäffer L; Balschmidt P; Møller KB; Møller NP
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4404-8. PubMed ID: 1852007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor.
    Zhang B; Roth RA
    Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras.
    Gustafson TA; Rutter WJ
    J Biol Chem; 1990 Oct; 265(30):18663-7. PubMed ID: 2170418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.
    Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K
    J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
    Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
    J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
    Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
    Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor.
    Bayne ML; Applebaum J; Underwood D; Chicchi GG; Green BG; Hayes NS; Cascieri MA
    J Biol Chem; 1989 Jul; 264(19):11004-8. PubMed ID: 2472386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding.
    Mynarcik DC; Williams PF; Schaffer L; Yu GQ; Whittaker J
    J Biol Chem; 1997 Jul; 272(30):18650-5. PubMed ID: 9228034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor.
    Xu Y; Margetts MB; Venugopal H; Menting JG; Kirk NS; Croll TI; Delaine C; Forbes BE; Lawrence MC
    Structure; 2022 Aug; 30(8):1098-1108.e6. PubMed ID: 35660159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding.
    Chrudinová M; Žáková L; Marek A; Socha O; Buděšínský M; Hubálek M; Pícha J; Macháčková K; Jiráček J; Selicharová I
    J Biol Chem; 2018 Oct; 293(43):16818-16829. PubMed ID: 30213860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of determinants that confer ligand specificity on the insulin receptor.
    Andersen AS; Kjeldsen T; Wiberg FC; Vissing H; Schäffer L; Rasmussen JS; De Meyts P; Møller NP
    J Biol Chem; 1992 Jul; 267(19):13681-6. PubMed ID: 1320025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
    Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
    Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting Insulin-like Growth Factors 1 and 2 into High-Affinity Ligands for Insulin Receptor Isoform A by the Introduction of an Evolutionarily Divergent Mutation.
    Macháčková K; Chrudinová M; Radosavljević J; Potalitsyn P; Křížková K; Fábry M; Selicharová I; Collinsová M; Brzozowski AM; Žáková L; Jiráček J
    Biochemistry; 2018 Apr; 57(16):2373-2382. PubMed ID: 29608283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function.
    Faria TN; Blakesley VA; Kato H; Stannard B; LeRoith D; Roberts CT
    J Biol Chem; 1994 May; 269(19):13922-8. PubMed ID: 8188672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes encoding receptors for insulin and insulin-like growth factor I are expressed in Xenopus oocytes and embryos.
    Scavo L; Shuldiner AR; Serrano J; Dashner R; Roth J; de Pablo F
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6214-8. PubMed ID: 1648732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth.
    Zhang W; Zong CS; Hermanto U; Lopez-Bergami P; Ronai Z; Wang LH
    Mol Cell Biol; 2006 Jan; 26(2):413-24. PubMed ID: 16382134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors.
    Frattali AL; Pessin JE
    J Biol Chem; 1993 Apr; 268(10):7393-400. PubMed ID: 8463272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.